// App-Quantinova.ai

1586 : Recovery and characterization of circulating tumor cells (CTCs) in cryopreserved metastatic castrate-resistant prostate cancer (mCRPC) patient samples

Researchers

Presenter

  • David Lu

Principal Investigators

  • Melissa Harvey

  • Ravi Madan

  • Dena Marrinucci

  • Jeffrey Schlom

  • James Gulley

  • Ryan Dittamore

  • Christopher Heery

  • Jennifer Marte

  • Sharon Beasley

  • Mark Landers

  • Rachel Krupa

  • Jessica Louw

  • Justin Wahl

  • Natalee Bales

Medical Centers

  • National Cancer Institute, Bethesda, MD

  • Epic Sciences, Inc., San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Androgen receptor

  • Phosphatase and tensin homolog

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved